200 related articles for article (PubMed ID: 37874419)
21. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
22. Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma.
Zeng Z; Zhang X; Li D; Li J; Yuan J; Gu L; Xiong X
Front Oncol; 2020; 10():836. PubMed ID: 32528897
[No Abstract] [Full Text] [Related]
23. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.
Xue J; Li Y; Yi J; Jiang H
Gastroenterol Res Pract; 2019; 2019():6746970. PubMed ID: 31885544
[TBL] [Abstract][Full Text] [Related]
24. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
Zhou HY; Wu CQ; Bi EX
World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
[TBL] [Abstract][Full Text] [Related]
25. Lin28B is a novel prognostic marker in gastric adenocarcinoma.
Hu Q; Peng J; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Liu S; Wang H
Int J Clin Exp Pathol; 2014; 7(8):5083-92. PubMed ID: 25197381
[TBL] [Abstract][Full Text] [Related]
26. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis.
Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C
J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Mao R; Liu K; Zhao N; Guo P; Wu Y; Wang Z; Liu Y; Zhang T
Aging (Albany NY); 2021 Jul; 13(13):17734-17767. PubMed ID: 34247148
[TBL] [Abstract][Full Text] [Related]
28. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG; Lyu SI; Laible M; Wöll S; Türeci Ö; Şahin U; Alakus H; Fahrig L; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Transl Med; 2023 Aug; 21(1):552. PubMed ID: 37592303
[TBL] [Abstract][Full Text] [Related]
29. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
Li Y; Fan Y; Xu J; Huo L; Scott AW; Jin J; Yang B; Shao S; Ma L; Wang Y; Yao X; Pool Pizzi M; Sewastjanow Da Silva M; Zhang G; Zhuo L; Cho EJ; Dalby KN; Shanbhag ND; Wang Z; Li W; Song S; Ajani JA
J Exp Clin Cancer Res; 2022 Aug; 41(1):257. PubMed ID: 35996148
[TBL] [Abstract][Full Text] [Related]
30. GLIS3, a novel prognostic indicator of gastric adenocarcinoma, contributes to the malignant biological behaviors of tumor cells via modulating TGF-β1/TGFβR1/Smad1/5 signaling pathway.
Zhang Y; Wang B; Song H; Han M
Cytokine; 2023 Oct; 170():156342. PubMed ID: 37651918
[TBL] [Abstract][Full Text] [Related]
31. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
Wang L; Li HG; Xia ZS; Lü J; Peng TS
Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
[TBL] [Abstract][Full Text] [Related]
33. Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma.
Chen L; Xiong Z; Zhao H; Teng C; Liu H; Huang Q; Wanggou S; Li X
Front Oncol; 2022; 12():889351. PubMed ID: 36033495
[TBL] [Abstract][Full Text] [Related]
34. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
35. Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDH
Wang S; Li L; Zuo S; Kong L; Wei J; Dong J
Front Immunol; 2022; 13():869061. PubMed ID: 36248907
[TBL] [Abstract][Full Text] [Related]
36. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
[TBL] [Abstract][Full Text] [Related]
37. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
38. SPP1 Regulates Radiotherapy Sensitivity of Gastric Adenocarcinoma via the Wnt/Beta-Catenin Pathway.
Sun G; Shang Z; Liu W
J Oncol; 2021; 2021():1642852. PubMed ID: 34367279
[TBL] [Abstract][Full Text] [Related]
39. The Significance of HOXC11 and LSH in Survival Prediction in Gastric Adenocarcinoma.
Peng X; Sun J; Long Y; Xiao D; Zhou J; Tao Y; Liu S
Onco Targets Ther; 2021; 14():1517-1529. PubMed ID: 33688200
[TBL] [Abstract][Full Text] [Related]
40. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
